These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity. Mwakingwe-Omari A; Healy SA; Lane J; Cook DM; Kalhori S; Wyatt C; Kolluri A; Marte-Salcedo O; Imeru A; Nason M; Ding LK; Decederfelt H; Duan J; Neal J; Raiten J; Lee G; Hume JCC; Jeon JE; Ikpeama I; Kc N; Chakravarty S; Murshedkar T; Church LWP; Manoj A; Gunasekera A; Anderson C; Murphy SC; March S; Bhatia SN; James ER; Billingsley PF; Sim BKL; Richie TL; Zaidi I; Hoffman SL; Duffy PE Nature; 2021 Jul; 595(7866):289-294. PubMed ID: 34194041 [TBL] [Abstract][Full Text] [Related]
26. Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens. Bettencourt P Front Immunol; 2020; 11():190. PubMed ID: 32153565 [No Abstract] [Full Text] [Related]
27. Down-selecting circumsporozoite protein-based malaria vaccine: A comparison of malaria sporozoite challenge model. Amelia F; Iyori M; Emran TB; Yamamoto DS; Genshi K; Otsuka H; Onoue Y; Yusuf Y; Islam A; Yoshida S Parasite Immunol; 2019 May; 41(5):e12624. PubMed ID: 30883819 [TBL] [Abstract][Full Text] [Related]
28. Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax. Nardin EH; Nussenzweig V; Nussenzweig RS; Collins WE; Harinasuta KT; Tapchaisri P; Chomcharn Y J Exp Med; 1982 Jul; 156(1):20-30. PubMed ID: 7045272 [TBL] [Abstract][Full Text] [Related]
34. Theoretical Implications of a Pre-Erythrocytic Plasmodium vivax Vaccine for Preventing Relapses. White M; Amino R; Mueller I Trends Parasitol; 2017 Apr; 33(4):260-263. PubMed ID: 28077251 [TBL] [Abstract][Full Text] [Related]
35. Understanding the Liver-Stage Biology of Malaria Parasites: Insights to Enable and Accelerate the Development of a Highly Efficacious Vaccine. Mo AX; McGugan G Am J Trop Med Hyg; 2018 Oct; 99(4):827-832. PubMed ID: 30141395 [TBL] [Abstract][Full Text] [Related]
36. Five decades of clinical assessment of whole-sporozoite malaria vaccines. Nunes-Cabaço H; Moita D; Prudêncio M Front Immunol; 2022; 13():977472. PubMed ID: 36159849 [TBL] [Abstract][Full Text] [Related]
37. Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity. Bijker EM; Bastiaens GJ; Teirlinck AC; van Gemert GJ; Graumans W; van de Vegte-Bolmer M; Siebelink-Stoter R; Arens T; Teelen K; Nahrendorf W; Remarque EJ; Roeffen W; Jansens A; Zimmerman D; Vos M; van Schaijk BC; Wiersma J; van der Ven AJ; de Mast Q; van Lieshout L; Verweij JJ; Hermsen CC; Scholzen A; Sauerwein RW Proc Natl Acad Sci U S A; 2013 May; 110(19):7862-7. PubMed ID: 23599283 [TBL] [Abstract][Full Text] [Related]
38. Protection against a malaria challenge by sporozoite inoculation. Roestenberg M; McCall M; Hopman J; Wiersma J; Luty AJ; van Gemert GJ; van de Vegte-Bolmer M; van Schaijk B; Teelen K; Arens T; Spaarman L; de Mast Q; Roeffen W; Snounou G; Rénia L; van der Ven A; Hermsen CC; Sauerwein R N Engl J Med; 2009 Jul; 361(5):468-77. PubMed ID: 19641203 [TBL] [Abstract][Full Text] [Related]
39. The Development of Whole Sporozoite Vaccines for Itsara LS; Zhou Y; Do J; Grieser AM; Vaughan AM; Ghosh AK Front Immunol; 2018; 9():2748. PubMed ID: 30619241 [TBL] [Abstract][Full Text] [Related]
40. Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine. Luke TC; Hoffman SL J Exp Biol; 2003 Nov; 206(Pt 21):3803-8. PubMed ID: 14506215 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]